Stem Cell Therapy Market, By Cell Source (Adult Stem Cells, Induced Pluripotent Stem Cells, Embryonic Stem Cells, Others), By Application (Musculoskeletal Disorders, Wounds and Injuries, Cancer, Autoimmune Disorders, Others), By End User (Hospitals, Cell Banks , Academic and Research Institutes), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

Published In : May 2024

Code : CMI2848

Pages :153

Formats :

Excel and PDF

Industry : Biotechnology

Stem Cell Therapy Market Size and Trends

Global stem cell therapy market is estimated to be valued at USD 15.15 Bn in 2024 and is expected to reach USD 63.23 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 22.6% from 2024 to 2031.

Stem Cell Therapy Market Key Factors

To learn more about this report, request sample copy

Stem cell therapy has witnessed huge adoption in recent years, owing to advancement in regulatory framework governing stem cell research and clinical applications. Rising prevalence of chronic diseases and success of stem cell based therapies to treat conditions such as cancer and blood disorders can drive the market growth. Furthermore, increasing public-private investments to develop innovative stem cell solutions for diseases like myocardial infarction can drive the stem cell therapy market growth during the forecast period. The number of clinical trials involving stem cells has significantly increased in the last few years, indicating the promise of this approach for both rare and common diseases. This is anticipated to provide new opportunities and drive future demand.

Increasing Manufacturing Facility Expansion by Key Market Players

Increasing manufacturing facility expansion by key market players is expected to drive the global stem cell therapy market growth over the forecast period. For instance, in October 2023, Bayer AG, a global pharmaceutical company, announced the opening of its first cell therapy facility in California, U.S., to create the capacity to bring cell therapies to patients on a global scale.

/p>Increasing Inorganic Growth Strategies among Key Market Players

Increasing adoption of inorganic growth strategies such as partnerships by key market players is expected to drive the market growth over the forecast period. For instance, in June 2022, The Melbourne node of the Novo Nordisk Foundation Center for Stem Cell Medicine (reNEW) announced a partnership with Murdoch Children's, the University of Copenhagen, and Leiden University Medical Center in the Netherlands, for stem cell research that will develop new treatments for cancer, diabetes and heart disease has been launched at the Murdoch Children’s Research Centre (MCRI).